Company intelligence / Profile preview

Biograph

Silicon Valley / San Francisco Bay Area, California, United Stateslinkedin.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Biograph offers advanced preventive health evaluations using over 1,000 data points across more than 30 assessments. The company provides two membership tiers—Core ($7,500/year) and Black ($15,000/year)—and claims significant actionable insights for over 15% of members. It has begun operations in Silicon Valley with imminent expansion to New York City and global ambitions[1][5].

No clinical trial results are reported as the company does not develop therapeutics.

Therapeutic areas: Other
Modalities: Data-driven health optimization (not therapeutics; focus on diagnostics and personalized protocols)
Industry: Non-Academic Healthcare

Partnerships

No major pharma/biotech partnerships disclosed; backed by prominent venture capital firms[1][5].

Beyond the preview

Go deeper on Biograph.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biograph.

Explore the full profile